Halin C, Neri D
Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zürich.
Crit Rev Ther Drug Carrier Syst. 2001;18(3):299-339.
Angiogenesis-the sprouting of new blood vessels from pre-existing ones-is a characteristic feature of relevant diseases such as cancer, some blinding ocular disorders, rheumatoid arthritis, and psoriasis. This article reviews recent progress in the generation of monoclonal antibodies, which recognize and target new blood vessels in vivo, while sparing mature vessels and healthy tissues. The use of such antibodies as selective "molecular vehicles" is likely to open new important diagnostic and therapeutic opportunities.
血管生成——从已有的血管中长出新血管——是癌症、某些致盲性眼部疾病、类风湿性关节炎和牛皮癣等相关疾病的一个特征。本文综述了单克隆抗体生成方面的最新进展,这些单克隆抗体在体内能够识别并靶向新血管,同时不损伤成熟血管和健康组织。将这类抗体用作选择性“分子载体”可能会带来新的重要诊断和治疗机会。